The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Up­dat­ed: Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al

10 months ago
R&D
Pharma

Tak­ing ad­van­tage of re­cent suc­cess­es, Roche will push obe­si­ty drugs faster, flirts with M&A

10 months ago
Pharma

No­vo Nordisk con­sid­ers an­oth­er fa­cil­i­ty; Lon­za’s new CEO shares his pri­or­i­ties

10 months ago

Sanofi eyes RSV an­ti­body for its next block­buster while Dupix­ent brings in record sales

10 months ago
Pharma

BeiGene plots to fur­ther build its man­u­fac­tur­ing mus­cle out­side of Chi­na

10 months ago
China

In­di­an man­u­fac­tur­er Bras­si­ca hit with warn­ing let­ter af­ter em­ploy­ees faked da­ta re­sults

10 months ago
FDA+

Pfiz­er lifts cur­tain on $740M+ ex­ten­sion at API man­u­fac­tur­ing site in Sin­ga­pore

10 months ago
Pharma

The obe­si­ty drug race is be­ing fought on the man­u­fac­tur­ing floor as GLP-1 ri­vals make plans to catch lead­ers

10 months ago
Pharma
In Focus

Ag­i­lent Tech­nolo­gies to ac­quire CD­MO Biovec­tra for $925M

10 months ago
Deals

Catal­ent fin­ish­es Ger­man ex­pan­sion; Grü­nen­thal in­vests in Latin Amer­i­ca 

11 months ago

Sanofi seeks deep­er roots in In­dia with €400M hub ex­pan­sion

11 months ago

In­vest­ment firm launch­es with $100M for bio­pro­cess­ing en­tre­pre­neurs  

11 months ago
Financing

FDA warns Chi­nese drug­mak­er for se­ri­ous GMP record vi­o­la­tions

11 months ago
FDA+

Cor­den­Phar­ma in­jects €900M to boost GLP-1 man­u­fac­tur­ing in US and Eu­rope

11 months ago

J&J and Emer­gent set­tle Covid con­tract dis­pute; Siegfried names new CEO

11 months ago

FDA re­jects No­vo Nordisk’s once-week­ly in­sulin af­ter ques­tion­ing risks

11 months ago
FDA+

No­vo-part­nered 3D bio­print­ing biotech gets $70M+ from Cana­di­an gov­ern­ment

11 months ago
Financing

House com­mit­tee rais­es con­cerns on CDER-CBER mis­align­ment amid 2025 fund­ing markup

11 months ago
FDA+

Avid Bio’s 2024 rev­enue drops; Lotte Bio breaks ground on new $3.3B site 

11 months ago

As con­fi­dence falls, bio­phar­ma com­pa­nies take pre­cau­tions with Chi­nese part­ner­ships, sur­vey finds

11 months ago
China
Outsourcing

Sam­sung Bio pulls in $1.06B man­u­fac­tur­ing deal with un­named US phar­ma com­pa­ny

11 months ago
Deals

FDA says can­cer drug cis­platin is no longer in short­age

11 months ago
Pharma
FDA+

UniQure sells Mass­a­chu­setts man­u­fac­tur­ing site to Genezen as it con­tin­ues to down­size

11 months ago
Deals

Rovi teas­es ac­qui­si­tion of­fers for its CD­MO unit po­ten­tial­ly worth €2B to €3B

11 months ago
Deals
Pharma
First page Previous page 10111213141516 Next page Last page
A service from the Financial Times